المؤلفون: Ádám Széles 1,2, Petra Terézia Kovács 1, Anita Csizmarik 1, Melinda Váradi 1, Péter Riesz 1, Tamás Fazekas 1,2, Szilárd Váncsa 2,3,4, Péter Hegyi 2,3,4, Csilla Oláh 5, Stephan Tschirdewahn 5, Christopher Darr 5, Ulrich Krafft 5, Viktor Grünwald 5, Boris Hadaschik 5, Orsolya Horvath 6, Péter Nyirády 1, Tibor Szarvas 1,5,#

مصطلحات موضوعية: upper tract urothelial carcinoma, UTUC, sPD-L1, soluble programmed death ligand-1, biomarker, prognosis, immune checkpoint inhibitor therapy, chemotherapy, radical nephroureterectomy

Relation: https://doi.org/10.5281/zenodo.6603957; https://doi.org/10.5281/zenodo.6603958; oai:zenodo.org:6603958

الاتاحة: https://doi.org/10.5281/zenodo.6603958

المؤلفون: Ádám Széles 1,2, Petra Terézia Kovács 1, Anita Csizmarik 1, Melinda Váradi 1, Péter Riesz 1, Tamás Fazekas 1,2, Szilárd Váncsa 2,3,4, Péter Hegyi 2,3,4, Csilla Oláh 5, Stephan Tschirdewahn 5, Christopher Darr 5, Ulrich Krafft 5, Viktor Grünwald 5, Boris Hadaschik 5, Orsolya Horvath 6, Péter Nyirády 1 and Tibor Szarvas 1,5

مصطلحات موضوعية: mental disorders, upper tract urothelial carcinoma, UTUC, sPD-L1, soluble programmed death ligand-1, biomarker, prognosis, immune checkpoint inhibitor therapy, chemotherapy, radical nephroureterectomy

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d3378fa0c7d664166dd68a13b4232be